Epoetin alfa biosimilar - EmcureAlternative Names: Epofer; Recombinant human eyrthropoeitin - Emcure; rhu-EPO - Emcure
Latest Information Update: 30 Sep 2013
At a glance
- Originator Emcure Pharmaceuticals
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 05 Dec 2011 Launched prior to December 2011 for Anaemia in India (Parenteral)